United Therapeutics (UTHR) Amortization of Deferred Charges (2009 - 2016)

United Therapeutics has reported Amortization of Deferred Charges for 8 years, with the latest figure at $100000.0 in Q1 2016.

• Quarterly Amortization of Deferred Charges fell 95.0% year-over-year to $100000.0 in Q1 2016, while the trailing twelve-month figure through Jun 2016 was $941000.0 (down 91.46% YoY) and the FY2015 annual result came in at $5.9 million, down 52.3% from the prior year.
• Amortization of Deferred Charges slipped to $100000.0 in Q1 2016 per UTHR's latest filing, from $433000.0 in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $3.4 million in Q3 2014 and troughed at $100000.0 in Q1 2016.
• A 5-year average of $2.5 million and a median of $3.0 million in 2012 frame the typical range for Amortization of Deferred Charges.
• The sharpest annual moves came in 2013 and 2016: Amortization of Deferred Charges surged 47.5% in 2013, then sank 95.0% in 2016.
• Over 5 years, Amortization of Deferred Charges stood at $2.2 million in 2012, then soared by 47.5% to $3.2 million in 2013, then retreated by 21.98% to $2.5 million in 2014, then slumped by 82.6% to $433000.0 in 2015, then slumped by 76.91% to $100000.0 in 2016.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $100000.0, $433000.0, and $408000.0 for Q1 2016, Q4 2015, and Q3 2015 respectively.